UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012253 |
|---|---|
| Receipt number | R000011464 |
| Scientific Title | Randomized phase II study comparing Gemcitabine chemoradiotherapy with Gemcitabine chemotherapy for unresectable locally advanced pancreatic cancer. |
| Date of disclosure of the study information | 2013/11/10 |
| Last modified on | 2017/11/11 10:22:14 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/11/08 21:53:54 | ||
| 2 | Update | 2013/11/13 13:43:36 | Key exclusion criteria |
|
| 3 | Update | 2014/11/10 07:49:04 | Publication of results |
|
| 4 | Update | 2015/05/15 14:00:44 | Date analysis concluded |
|
| 5 | Update | 2016/05/10 21:07:37 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2016/11/12 21:54:26 | Key inclusion criteria |
|
| 7 | Update | 2017/05/16 19:06:22 | Publication of results |
|
| 8 | Update | 2017/11/11 10:22:14 | Recruitment status Publication of results |
